Edgar Engleman

Clinical Trials

• Recruiting Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies
• Not Recruiting Mixed Chimera Allo Transplantation in Multiple Myeloma
• Not Recruiting Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
• Not Recruiting Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
• Not Recruiting Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
• Recruiting Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)